Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €26.10 EUR
Change Today +0.55 / 2.16%
Volume 98.5K
AFX On Other Exchanges
Symbol
Exchange
AFX is not on other exchanges.
As of 3:05 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

carl zeiss meditec ag - br (AFX) Snapshot

Open
€25.53
Previous Close
€25.54
Day High
€26.48
Day Low
€25.53
52 Week High
08/3/15 - €26.48
52 Week Low
12/16/14 - €19.83
Market Cap
2.1B
Average Volume 10 Days
46.9K
EPS TTM
€0.80
Shares Outstanding
81.3M
EX-Date
03/19/15
P/E TM
32.6x
Dividend
€0.40
Dividend Yield
1.53%
Current Stock Chart for CARL ZEISS MEDITEC AG - BR (AFX)

Related News

No related news articles were found.

carl zeiss meditec ag - br (AFX) Related Businessweek News

View More BusinessWeek News

carl zeiss meditec ag - br (AFX) Details

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It provides various products and services in the fields of ophthalmology; neurosurgery; plastic and reconstructive; spine; ear, nose, and throat (ENT); dentistry; gynecology; and oncology. The company’s ophthalmic equipment and systems are used for the diagnosis, progress control, treatment, and follow-up treatment of ophthalmic conditions, such as vision defects (refraction), cataract, glaucoma, and retinal disorders. It also offers laser and diagnostic systems for ophthalmology; ophthalmic implants, including intraocular lenses; and consumables. In addition, the company provides surgical microscopes and visualization solutions for ENT surgeries, or neurosurgery, as well as used to assist with the removal of tumors; and treatment of vascular diseases and functional disorders, as well as provides intraoperative radiation therapy. Carl Zeiss Meditec AG serves physicians in various fields and hospitals through a distribution network of 40 sales companies and 100 agencies. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

2,967 Employees
Last Reported Date: 04/30/15
Founded in 2002

carl zeiss meditec ag - br (AFX) Top Compensated Officers

Chairman of Management Board, Chief Executive...
Total Annual Compensation: €583.5K
Chief Financial Officer and Member of the Man...
Total Annual Compensation: €393.8K
Chief Sales Officer and Member of the Managem...
Total Annual Compensation: €416.5K
Compensation as of Fiscal Year 2014.

carl zeiss meditec ag - br (AFX) Key Developments

Carl Zeiss Meditec AG Reports Earnings Results for the Six Months Ended March 2015; Provides Earnings Guidance for Full Year Ended September 2015

Carl Zeiss Meditec AG reported earnings results for the six months ended March 2015. Revenue in the six months to March rose 8% to EUR 498 million. Earnings before interest and tax (EBIT) fell to EUR 61 million from EUR 63.7 million, pushed lower by currency hedging effects. The EBIT margin reached 12.2% in the first six months of the fiscal year, down from 13.8% in the prior-year period. For the full year ended September 2015, EBIT margin is expected to be in the range of 13% to 15% in the medium term. Revenue is expected to be between EUR 960 million and EUR 1 billion.

Carl Zeiss Meditec AG Announces Preliminary Earnings Results for the First Half of 2015; Provides Earnings Guidance for the First Half of 2015

Carl Zeiss Meditec AG announced preliminary earnings results for the first half of 2015. For the quarter, the company achieved revenue of approximately EUR 498 million. This corresponds to a growth rate against the previous year of approx. 8%. Earnings before interest & taxes (EBIT) amounted to approx. EUR 61 million, a decline of 4% against the previous year. EBIT reached approx. EUR 68 million, which is 5% above the comparable previous year's value. For the first half of 2015, the company’s earnings per share (EPS) are expected at around EUR 0.37. This corresponds to a decline of 24% against the previous year and is mainly related to a negative result from currency hedging.

Carl Zeiss Meditec AG, H1 2015 Earnings Call, May 07, 2015

Carl Zeiss Meditec AG, H1 2015 Earnings Call, May 07, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFX:GR €26.10 EUR +0.55

AFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ellex Medical Lasers Ltd A$0.32 AUD 0.00
IRIDEX Corp $7.09 USD -0.07
Lumenis Ltd $13.85 USD -0.01
Synergetics USA Inc $4.72 USD -0.11
Topcon Corp ¥2,285 JPY -500.00
View Industry Companies
 

Industry Analysis

AFX

Industry Average

Valuation AFX Industry Range
Price/Earnings 32.7x
Price/Sales 2.3x
Price/Book 3.1x
Price/Cash Flow 32.6x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARL ZEISS MEDITEC AG - BR, please visit www.meditec.zeiss.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.